Efficient synthesis of (5-oxo-6,7-dihydro-4H-[1,2,4]triazolo-[1,5-a]pyrimidin-6-yl)acetanilides based on the recyclization of N-arylitaconimides with 3-amino[1,2,4]triazoles
- 27 March 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Russian Chemical Bulletin
- Vol. 70 (3), 520-526
- https://doi.org/10.1007/s11172-021-3118-2
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- 1,2,4-Triazolo[1,5-a]pyrimidines in drug designEuropean Journal of Medicinal Chemistry, 2019
- The synthesis and evaluation of triazolopyrimidines as anti-tubercular agentsBioorganic & Medicinal Chemistry, 2017
- Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sicknessNature, 2016
- Pyrazole clubbed triazolo[1,5-a]pyrimidine hybrids as an anti-tubercular agents: Synthesis, in vitro screening and molecular docking studyBioorganic & Medicinal Chemistry, 2015
- A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malariaScience Translational Medicine, 2015
- Synthesis and Evaluation of 1,2,4-Triazolo[1,5-a]pyrimidines as Antibacterial Agents Against Enterococcus faeciumJournal of Medicinal Chemistry, 2015
- Preclinical Characterization of PF-00868554, a Potent Nonnucleoside Inhibitor of the Hepatitis C Virus RNA-Dependent RNA PolymeraseAntimicrobial Agents and Chemotherapy, 2009
- Essramycin: A First Triazolopyrimidine Antibiotic Isolated from Nature†The Journal of Antibiotics, 2008
- Allosteric Inhibitors of Hepatitis C Polymerase: Discovery of Potent and Orally Bioavailable Carbon-Linked DihydropyronesJournal of Medicinal Chemistry, 2007
- Synthesis and Evaluation of Anti-HIV-1 and Anti-HSV-1 Activities of 4H-[1,2,4]-Triazolo [1,5-a]pyrimidin-5-one DerivativesArzneimittelforschung, 2002